Equities

RaySearch Laboratories AB (publ)

RaySearch Laboratories AB (publ)

Actions
  • Price (EUR)14.12
  • Today's Change0.540 / 3.98%
  • Shares traded0.00
  • 1 Year change+86.77%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of SEK
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments344160103
Total Receivables, Net414398384
Total Inventory9.321430
Prepaid expenses3655--
Other current assets, total------
Total current assets802628516
Property, plant & equipment, net590649667
Goodwill, net------
Intangibles, net530519523
Long term investments------
Note receivable - long term245510
Other long term assets------
Total assets1,9531,8761,745
LIABILITIES
Accounts payable422449
Accrued expenses4217--
Notes payable/short-term debt000
Current portion long-term debt/capital leases975870
Other current liabilities, total494515398
Total current liabilities675614517
Total long term debt432497492
Total debt529555562
Deferred income tax110107108
Minority interest------
Other liabilities, total0.880.74--
Total liabilities1,2171,2191,116
SHAREHOLDERS EQUITY
Common stock1717--
Additional paid-in capital1.981.98--
Retained earnings (accumulated deficit)722640--
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(5.87)(2.37)628
Total equity735657628
Total liabilities & shareholders' equity1,9531,8761,745
Total common shares outstanding343434
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.